# A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

> **NCT00191412** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 41 (—)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT00191412
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 41 (—)
- **Last updated:** 2007-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00191412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00191412, "A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00191412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*